UCP2 and metabolic dysfunction-associated steatotic liver disease: Additionally, increased expression of UCP2 induced by TRPV1 exerted a protective antioxidant effect on the liver in non-alcoholic fatty liver disease and on vascular endothelium during hyperglycemia [18].